URGN icon

UroGen Pharma
URGN

Overview Fund Activity

43 hedge funds and large institutions have $454M invested in UroGen Pharma in 2018 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 21 increasing their positions, 7 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
43
Holders Change
+2
Holders Change %
+4.88%
% of All Funds
0.99%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.09%
New
10
Increased
21
Reduced
7
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
MMH
Menora Mivtachim Holdings
Israel
+$26.6M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$20.9M
3
EC
EcoR1 Capital
California
+$20M
4
CI
Clal Insurance
Israel
+$13.9M
5
CCM
Consonance Capital Management
New York
+$11.4M

Top Sellers

1
PA
Perceptive Advisors
New York
-$7.41M
2
SIM
Spark Investment Management
New York
-$2.63M
3
LCM
Laurion Capital Management
New York
-$1.77M
4
LSC
Lyon Street Capital
California
-$1.18M
5
HCM
Highline Capital Management
New York
-$1.15M
Name Holding Trade Value Shares
Change 		Shares
Change %
Macquarie Group
51
Macquarie Group
Australia
– -$11K -300 Closed
1 2
3